受容体 (JP Patent Analysis Report)
The Technical Field "受容体" had 98 patent application filings in the most recent period (2023-01-01 to 2023-04-30). This is a significantly decreased of -719 filings (-88.0%) over 817 they had in the same period of the previous year (2022-01-01 to 2022-04-30). This report also includes technical terms related to " 受容器 ", " 摂受体 ", " 摂受器 ", " リセプタ ", " リセプター ", " レセプタ ", " レセプター " in the search set.
The highest number of filings in 2018 with 3,266 cases, and their lowest number in 2023 with 171 cases.
The mean of the number of filings over the last 5 years (2019 to 2024, 11,112 cases in total) is 1,852, and the median is 2,503. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 1,852 patents |
| Std Dev | 1,264 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 171 cases | -92.8 % |
| 2022 year | 2,386 cases | -12.05 % |
| 2021 year | 2,713 cases | +3.55 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 受容体 for the period of the last 10 years (2015-01-01 to 2024-12-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 受容体, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
受容体, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 受容体 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 23,622 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
受容体
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 受容体 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Comparing the number of applications of each company, リジェネロン・ファーマシューティカルズ・インコーポレイテッド has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 5 cases, followed by エフホフマン-ラロシュアーゲー with 1 cases.
| Name | Cases |
|---|---|
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 5 cases |
| エフホフマン-ラロシュアーゲー | 1 cases |
| 武田薬品工業株式会社 | 1 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 1 cases |
| 中外製薬株式会社 | 1 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Comparing the number of applications of each company, ノバルティスアーゲー has the highest number of joint applications in the last for the target period (2015 to 2025) with 368 cases, followed by リジェネロン・ファーマシューティカルズ・インコーポレイテッド with 326 cases.
| Name | Cases |
|---|---|
| ノバルティスアーゲー | 368 cases |
| リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 326 cases |
| ブリストル-マイヤーズスクイブカンパニー | 251 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 244 cases |
| ジェネンテックインコーポレイテッド | 240 cases |
| エフホフマン-ラロシュアーゲー | 175 cases |
| 武田薬品工業株式会社 | 144 cases |
| 中外製薬株式会社 | 109 cases |
| メルク・シャープ・アンド・ドーム・コーポレーション | 49 cases |
| グラクソグループリミテッド | 7 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 受容体 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2023 to 2025).
Among the top coapplicants, エフホフマン-ラロシュアーゲー has the highest number of joint applications in the last in the last 3 years (2023 to 2025) with 1 cases, followed by 武田薬品工業株式会社 with 1 cases.
| Name | Cases |
|---|---|
| エフホフマン-ラロシュアーゲー | 1 cases |
| 武田薬品工業株式会社 | 1 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 1 cases |
Trends in filing of joint patent applications for the target period (2015 to 2025).
Among the top coapplicants, ノバルティスアーゲー has the highest number of joint applications in the last for the target period (2015 to 2025) with 368 cases, followed by ブリストル-マイヤーズスクイブカンパニー with 251 cases.
| Name | Cases |
|---|---|
| ノバルティスアーゲー | 368 cases |
| ブリストル-マイヤーズスクイブカンパニー | 251 cases |
| ザリージェンツオブザユニバーシティオブカリフォルニア | 244 cases |
| ジェネンテックインコーポレイテッド | 240 cases |
| エフホフマン-ラロシュアーゲー | 175 cases |
| 武田薬品工業株式会社 | 144 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by 受容体’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 受容体’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with ノバルティスアーゲー
受容体 filed 368 joint applications with ノバルティスアーゲー for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 97 cases in total) is 16.2, and the median is 17.5. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2016 with 83 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 16.2 patents |
| Std Dev | 12.7 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 17 cases | -5.56 % |
| 2021 year | 18 cases | -40.0 % |
| 2020 year | 30 cases | -6.25 % |
Trends in filing of joint patent applications with エフホフマン-ラロシュアーゲー
受容体 filed 175 joint applications with エフホフマン-ラロシュアーゲー for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 56 cases in total) is 9.3, and the median is 7.0. The coefficient of variation (standard deviation/mean) is 0.9, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2015 with 44 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 9.3 patents |
| Std Dev | 8.8 |
| COV | 0.9 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 0 cases | -100 % |
| 2022 year | 16 cases | +220 % |
| 2021 year | 5 cases | -44.4 % |
Trends in filing of joint patent applications with 武田薬品工業株式会社
受容体 filed 144 joint applications with 武田薬品工業株式会社 for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 65 cases in total) is 10.8, and the median is 10.5. The coefficient of variation (standard deviation/mean) is 0.9, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2019 with 29 cases, and their lowest number in 2023 with 1 cases.
| Index | Value |
|---|---|
| Average | 10.8 patents |
| Std Dev | 9.7 |
| COV | 0.9 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 1 cases | -87.5 % |
| 2022 year | 8 cases | -38.5 % |
| 2021 year | 13 cases | -7.14 % |
Trends in filing of joint patent applications with ジェネンテックインコーポレイテッド
受容体 filed 240 joint applications with ジェネンテックインコーポレイテッド for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 84 cases in total) is 14.0, and the median is 15.0. The coefficient of variation (standard deviation/mean) is 0.9, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2021 to 2024). The highest number of filings in 2015 with 64 cases, and their lowest number in 2023 with 0 cases.
| Index | Value |
|---|---|
| Average | 14.0 patents |
| Std Dev | 12.2 |
| COV | 0.9 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 26 cases | -7.14 % |
| 2021 year | 28 cases | +367 % |
| 2020 year | 6 cases | -75.0 % |
Trends in filing of joint patent applications with ザリージェンツオブザユニバーシティオブカリフォルニア
受容体 filed 244 joint applications with ザリージェンツオブザユニバーシティオブカリフォルニア for the analysis period (2015 to 2025).
The mean of the number of filings over the last 5 years (2019 to 2024, 114 cases in total) is 19.0, and the median is 24.0. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2016 with 42 cases, and their lowest number in 2023 with 1 cases.
| Index | Value |
|---|---|
| Average | 19.0 patents |
| Std Dev | 13.8 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2023 year | 1 cases | -95.5 % |
| 2022 year | 22 cases | -21.43 % |
| 2021 year | 28 cases | -24.32 % |
Information on important patents (JP)
The following shows JP patents held by 受容体 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 受容体’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 受容体 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 10 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.0 times. The most recently Invalidation Trial patent is 特許5419866 "新たな医薬組成物" (Invalidation Trial day 2024-05-30) , next is 特許6144713 "新たな医薬組成物" (Invalidation Trial day 2024-05-30) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許5419866 | 新たな医薬組成物 | 2024-05-30 |
| 2 | 特許6144713 | 新たな医薬組成物 | 2024-05-30 |
| 3 | 特許5735078 | 新たな医薬組成物 | 2024-05-30 |
| 4 | 特許6560289 | 新たな医薬組成物 | 2024-05-30 |
| 5 | 特許7258832 | 多発性硬化症を処置するためのＳ１Ｐ受容体モジュレーター | 2024-05-08 |
| 6 | 特許7185426 | Ｓ１Ｐ受容体モジュレーターの投与計画 | 2023-07-10 |
| 7 | 特許6931019 | 多発性硬化症を処置するためのＳ１Ｐ受容体モジュレーター | 2023-06-30 |
| 8 | 特許7016341 | ＰＤ－１軸結合アンタゴニスト及びＴＩＧＩＴ阻害剤を使用するがんの治療方法 | 2023-03-27 |
| 9 | 特許6278598 | 細胞傷害誘導治療剤 | 2022-03-31 |
| 10 | 特許6773929 | 細胞傷害誘導治療剤 | 2022-03-31 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 5 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.2. The most invalidation trial patent is 特許5906333 "プロタンパク質コンベルターゼスブチリシンケクシン９型（ＰＣＳＫ９）に対する抗原結合タンパク質" (2 times) , and the next most invalidation trial patent is 特許6144713 "新たな医薬組成物" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許5906333 | プロタンパク質コンベルターゼスブチリシンケクシン９型（ＰＣＳＫ９）に対する抗原結合タンパク質 | 2 times |
| 2 | 特許6144713 | 新たな医薬組成物 | 1 times |
| 3 | 特許6417431 | 複数分子の抗原に繰り返し結合する抗原結合分子 | 1 times |
| 4 | 特許6293103 | 自己緩衝タンパク質製剤 | 1 times |
| 5 | 特許6560289 | 新たな医薬組成物 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 8 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7438604 "ＳＡＲＳ－ＣＯＶ－２ ｍＲＮＡドメインワクチン" (Opposition day 2024-08-23) , next is 特許7448953 "眼疾患のための細胞モデル及び治療関連出願への相互参照" (Opposition day 2024-04-17) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7438604 | ＳＡＲＳ－ＣＯＶ－２ ｍＲＮＡドメインワクチン | 2024-08-23 |
| 2 | 特許7448953 | 眼疾患のための細胞モデル及び治療関連出願への相互参照 | 2024-04-17 |
| 3 | 特許7289655 | ＰＡＭＰＳ及びＤＡＭＰＳの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2023-12-12 |
| 4 | 特許7210036 | アルツハイマー病および他の神経変性障害のためのバイオマーカーおよび診断方法 | 2023-07-20 |
| 5 | 特許7188087 | 一本鎖オリゴヌクレオチド | 2023-06-12 |
| 6 | 特許7094269 | アンバーグリスノートを呈する香料素材のスクリーニング方法 | 2022-11-11 |
| 7 | 特許6988481 | 一本鎖オリゴヌクレオチド | 2022-07-04 |
| 8 | 特許6933898 | 養子細胞治療製品を製造するための誘導多能性幹細胞の適用 | 2022-03-07 |
Protested cases
List of latest Protested patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 39 patents Protest from third parties. The average number of Protest is 1.2 times. The most recently Protest patent is 特開2022-166114 "電子素子のための材料" (Protest day 2024-10-07) , next is 特表2023-514396 "抗菌組成物" (Protest day 2024-09-27) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2022-166114 | 電子素子のための材料 | 2024-10-07 |
| 2 | 特表2023-514396 | 抗菌組成物 | 2024-09-27 |
| 3 | 特表2022-546587 | 生物製剤の捕捉及び精製のための方法 | 2024-08-22 |
| 4 | 特開2022-081394 | 女性向け膀胱緊張緩解剤及びこれを含む経口摂取用組成物 | 2024-07-19 |
| 5 | 特許7599285 | 油中油型化粧料 | 2024-06-28 |
| 6 | 特表2022-546204 | 苦味受容体ブロッカー及びその同定方法 | 2024-02-22 |
| 7 | 特開2023-171429 | 新規リパーゼ及びその用途 | 2024-02-21 |
| 8 | 特開2023-052694 | 悪臭調節化合物の同定方法 | 2024-02-17 |
| 9 | 特開2022-187349 | 含硫化合物臭の抑制剤の探索方法 | 2024-02-17 |
| 10 | 特開2023-174085 | アンモニア臭の抑制剤の探索方法 | 2024-02-17 |
| 11 | 特開2023-055917 | ＰＡＭＰＳ及びＤＡＭＰＳの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2024-01-17 |
| 12 | 特許7549530 | ガラス容器に封入された凍結乾燥製剤 | 2023-11-30 |
| 13 | 特開2020-114266 | ＩｇＧ Ｆｃドメインを有する融合タンパク質の生産方法 | 2023-10-30 |
| 14 | 特許7438604 | ＳＡＲＳ－ＣＯＶ－２ ｍＲＮＡドメインワクチン | 2023-10-27 |
| 15 | 特表2021-520189 | プレバイオティック組成物及びその製造方法 | 2023-09-07 |
| 16 | 特開2023-098949 | 多発性硬化症を処置するためのＳ１Ｐ受容体モジュレーター | 2023-08-28 |
| 17 | 特開2023-093482 | Ｓ１Ｐ受容体モジュレーターの投与計画 | 2023-08-28 |
| 18 | 特許7507209 | がんを治療するための、ＰＤ－１アンタゴニスト及びＶＥＧＦＲ／ＦＧＦＲ／ＲＥＴチロシンキナーゼ阻害剤の組合せ | 2023-07-12 |
| 19 | 特許7568698 | 難治性ホジキンリンパ腫におけるニボルマブでのＰＤ－１遮断 | 2023-04-27 |
| 20 | 特許7491491 | てんかんの治療に使用するための組成物 | 2023-04-03 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 76 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.3. The most protest patent is 特開2017-061467 "血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用" (5 times) , and the next most protest patent is 特開2019-167366 "血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用" (4 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2017-061467 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 5 times |
| 2 | 特開2019-167366 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 4 times |
| 3 | 特開2020-114266 | ＩｇＧ Ｆｃドメインを有する融合タンパク質の生産方法 | 4 times |
| 4 | 特開2021-020944 | 基礎代謝亢進剤 | 2 times |
| 5 | 特許7152399 | 悪臭中和剤を同定するための方法 | 2 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2022-01-01 ~ 2024-12-31), there were 484 patents Inspection from third parties. The average number of Inspection is 1.5 times. The most recently Inspection patent is 特表2024-510142 "甲状腺眼症の処置のための方法" (Inspection day 2024-12-26) , next is 特表2021-534220 "抗ＨＥＲ２ポリペプチド及びそれらの使用の方法" (Inspection day 2024-12-24) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特表2024-510142 | 甲状腺眼症の処置のための方法 | 2024-12-26 |
| 2 | 特表2021-534220 | 抗ＨＥＲ２ポリペプチド及びそれらの使用の方法 | 2024-12-24 |
| 3 | 特表2022-517767 | 無痕跡型リンカー及びそのタンパク質－コンジュゲート | 2024-12-23 |
| 4 | 特開2023-024691 | 形質導入および細胞プロセシングのための方法 | 2024-12-17 |
| 5 | 特表2022-513062 | Ｂ細胞悪性腫瘍を処置するために、操作されたＴ細胞を投薬する方法 | 2024-12-10 |
| 6 | 特開2023-062063 | 抗ＫＩＴ抗体及びその使用 | 2024-12-10 |
| 7 | 特表2022-516496 | キメラ受容体ポリペプチド及びその使用 | 2024-12-10 |
| 8 | 特表2022-532564 | 先駆制御性細胞栄養芽細胞およびその使用 | 2024-12-10 |
| 9 | 特表2021-525549 | 腫瘍特異的ネオ抗原およびその使用方法 | 2024-12-04 |
| 10 | 特表2022-547154 | 調節可能な制御のためのＣＡ２－ＩＬ１５融合タンパク質 | 2024-11-25 |
| 11 | 特表2022-516318 | カプセル化ポリヌクレオチド及び使用方法 | 2024-11-22 |
| 12 | 特表2022-514116 | 新規な癌抗原及び方法 | 2024-11-21 |
| 13 | 特許6231007 | ＢＣＭＡおよびＣＤ３に対する結合分子 | 2024-11-15 |
| 14 | 特許7250736 | ＢＣＭＡおよびＣＤ３に対する結合分子 | 2024-11-15 |
| 15 | 特許6378087 | ＢＣＭＡおよびＣＤ３に対する結合分子 | 2024-11-15 |
| 16 | 特開2017-195889 | ＢＣＭＡおよびＣＤ３に対する結合分子 | 2024-11-15 |
| 17 | 特表2022-545835 | 甲状腺眼症の治療方法 | 2024-11-07 |
| 18 | 特許7456699 | ＧＬＰ－１Ｒ受容体アゴニスト化合物及びその使用 | 2024-11-05 |
| 19 | 特表2022-538609 | 新規な癌抗原及び方法 | 2024-10-30 |
| 20 | 特表2023-506768 | 聴覚損失の予防及び治療のための組成物及び方法 | 2024-10-30 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 795 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.2. The most inspection patent is 特許6320473 "アロＮＫＴ細胞を用いた免疫療法およびそのためのＴ細胞抗原受容体（ＴＣＲ）遺伝子のα鎖領域が均一なＶα−Ｊαに再構成されている細胞および該細胞由来ＮＫＴ細胞のバンキング" (48 times) , and the next most inspection patent is 特開2019-167366 "血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用" (10 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6320473 | アロＮＫＴ細胞を用いた免疫療法およびそのためのＴ細胞抗原受容体（ＴＣＲ）遺伝子のα鎖領域が均一なＶα−Ｊαに再構成されている細胞および該細胞由来ＮＫＴ細胞のバンキング | 48 times |
| 2 | 特開2019-167366 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 10 times |
| 3 | 特開2017-061467 | 血管新生眼疾患を処置するためのＶＥＧＦアンタゴニストの使用 | 8 times |
| 4 | 特開2019-011372 | インターロイキン−６関連疾患の治療方法 | 7 times |
| 5 | 特開2016-155809 | 狭窄病変および血栓溶解療法のための剪断による制御放出 | 5 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2015-01-01 to 2024-12-31), 3,597 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.3. The most cited patent is 特許6082447 "複数分子の抗原に繰り返し結合する抗原結合分子" (36 times) , and the next most cited patent is 特許6778114 "イミド系タンパク質分解モジュレーター及び関連する使用方法" (36 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6082447 | 複数分子の抗原に繰り返し結合する抗原結合分子 | 36 times |
| 2 | 特許6778114 | イミド系タンパク質分解モジュレーター及び関連する使用方法 | 36 times |
| 3 | 特開2016-106631 | 非ヒト哺乳動物 | 28 times |
| 4 | 特許6731346 | 標的ＴＧＦβ阻害 | 24 times |
| 5 | 特許6425730 | ＰＤ−１に対するヒト抗体 | 23 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.